|Articles|December 1, 2001

Cyclosporine/PUVA approach to psoriasis raises cancer risk

Boston - Use of the immunosuppressant cyclosporine on patientswith psoriasis who have had substantial psoralen and ultra violet A lighttreatments show a sevenfold increase in the number of squamous cell cancertumors, according to Robert S. Stern, M.D.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME